Target intelligence / Profile preview

Solute carrier family 12 member 9 (SLC12A9)

Target
SLC12A9
Molecular classification
Transporter, Solute carrier, Cation-chloride cotransporter
01

Overview

SLC12A9 (Solute carrier family 12 member 9) encodes a protein that is a putative member of the cation-chloride cotransporter family, functioning as a transporter involved in potassium and chloride ion homeostasis and transmembrane transport[1][2][3][5]. Although the exact physiological role remains unclear, evidence suggests involvement in lysosomal ion flux and osmoregulation[2]. Genome-wide association studies have implicated SLC12A9 in cardiac function through genetic association with resting heart rate, while altered expression is linked to poor prognosis in certain cancers, such as uveal melanoma and colorectal cancer[1]. SLC12A9 is considered a transporter protein and a potential emerging therapeutic and prognostic target in disease[1][2].

Other names
CCC6CIP1hCCC6WO3.3cation-chloride cotransporter 6cation-chloride cotransporter-interacting protein 1potassium-chloride transporter 9solute carrier family 12 (potassium/chloride transporters), member 9
02

Biological functions

Chloride ion homeostasisChloride transmembrane transportPotassium ion homeostasisPredicted potassium:chloride symporter activityLysosomal ion fluxOsmoregulation
03

Disease associations

Cardiovascular disease (e.g., loci near SLC12A9 associated with variations in resting heart rate and potential influence on cardiac function)Cancer (e.g., linked to unfavorable prognosis in uveal melanoma and explored as a diagnostic/prognostic marker in colorectal cancer)Other (Capillary Malformation-Arteriovenous Malformation 2, Lymphatic Malformation 7)
04

Biomarkers

Potential prognostic biomarker in uveal melanomaPotential diagnostic/prognostic marker in colorectal cancer

Beyond the preview

Go deeper on Solute carrier family 12 member 9 (SLC12A9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 12 member 9 (SLC12A9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call